Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0603287 on November 21, 2003

Published online before print November 21, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0603287v1
75/2/314    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, Y. Y.
Right arrow Articles by Staal, F. J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, Y. Y.
Right arrow Articles by Staal, F. J. T.
(Journal of Leukocyte Biology. 2004;75:314-323.)
© 2004 by Society for Leukocyte Biology

Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity

Yuk Yin Ng*,{dagger}, Berris van Kessel*, Henk M. Lokhorst*, Miranda R. M. Baert{dagger}, Caroline M. M. van den Burg{dagger}, Andries C. Bloem* and Frank J. T. Staal{dagger},1

* Departments of Hematology and Immunology, University Medical Center Utrecht, The Netherlands; and
{dagger} Department of Immunology, Erasmus University Medical Center Rotterdam, The Netherlands

1 Correspondence: Department of Immunology, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail: f.staal{at}erasmusmc.nl

The replacement of bone marrow (BM) as a conventional source of stem cell (SC) by umbilical cord blood (UCB) and granulocyte-colony stimulating factor-mobilized peripheral blood SC (PBSC) has brought about clinical advantages. However, several studies have demonstrated that UCB CD34+ cells and PBSC significantly differ from BM CD34+ cells qualitatively and quantitatively. Here, we quantified the number of SC in purified BM, UCB CD34+ cells, and CD34+ PBSC using in vitro and in vivo assays for human hematopoietic SC (HSC) activity. A cobblestone area-forming cell (CAFC) assay showed that UCB CD34+ cells contained the highest frequency of CAFCwk6 (3.6- to tenfold higher than BM CD34+ cells and PBSC, respectively), and the engraftment capacity in vivo by nonobese diabetic/severe combined immunodeficiency repopulation assay was also significantly greater than BM CD34+, with a higher proportion of CD45+ cells detected in the recipients at a lower cell dose. To understand the molecular characteristics underlying these functional differences, we performed several DNA microarray experiments using Affymetrix gene chips, containing 12,600 genes. Comparative analysis of gene-expression profiles showed differential expression of 51 genes between BM and UCB CD34+ SC and 64 genes between BM CD34+ cells and PBSC. These genes are involved in proliferation, differentiation, apoptosis, and engraftment capacity of SC. Thus, the molecular expression profiles reported here confirmed functional differences observed among the SC sources. Moreover, this report provides new insights to describe the molecular phenotype of CD34+ HSC and leads to a better understanding of the discrepancy among the SC sources.

Key Words: peripheral blood stem cell • G-CSF • umbilical cord blood • bone marrow • microarray




This article has been cited by other articles:


Home page
Stem CellsHome page
S. M. Graham, J. K. Vass, T. L. Holyoake, and G. J. Graham
Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources
Stem Cells, December 1, 2007; 25(12): 3111 - 3120.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Zhao, A. Raouf, D. Kent, J. Khattra, A. Delaney, A. Schnerch, J. Asano, H. McDonald, C. Chan, S. Jones, et al.
A Modified Polymerase Chain Reaction-Long Serial Analysis of Gene Expression Protocol Identifies Novel Transcripts in Human CD34+ Bone Marrow Cells
Stem Cells, July 1, 2007; 25(7): 1681 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Martin-Rendon, S. J.M. Hale, D. Ryan, D. Baban, S. P. Forde, M. Roubelakis, D. Sweeney, M. Moukayed, A. L. Harris, K. Davies, et al.
Transcriptional Profiling of Human Cord Blood CD133+ and Cultured Bone Marrow Mesenchymal Stem Cells in Response to Hypoxia
Stem Cells, April 1, 2007; 25(4): 1003 - 1012.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago
Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors
Stem Cells, January 1, 2007; 25(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. A. Keller, S. Addya, R. Vadigepalli, B. Banini, K. Delgrosso, H. Huang, and S. Surrey
Transcriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulators
Physiol Genomics, December 13, 2006; 28(1): 114 - 128.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. G. Moneypenny, J. Shao, Y. Song, and E. P. Gallagher
MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells
Carcinogenesis, April 1, 2006; 27(4): 874 - 881.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Jaatinen, H. Hemmoranta, S. Hautaniemi, J. Niemi, D. Nicorici, J. Laine, O. Yli-Harja, and J. Partanen
Global Gene Expression Profile of Human Cord Blood-Derived CD133+ Cells
Stem Cells, March 1, 2006; 24(3): 631 - 641.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
A. Toren, B. Bielorai, J. Jacob-Hirsch, T. Fisher, D. Kreiser, O. Moran, S. Zeligson, D. Givol, A. Yitzhaky, J. Itskovitz-Eldor, et al.
CD133-Positive Hematopoietic Stem Cell "Stemness" Genes Contain Many Genes Mutated or Abnormally Expressed in Leukemia
Stem Cells, September 1, 2005; 23(8): 1142 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Wagner, R. Saffrich, U. Wirkner, V. Eckstein, J. Blake, A. Ansorge, C. Schwager, F. Wein, K. Miesala, W. Ansorge, et al.
Hematopoietic Progenitor Cells and Cellular Microenvironment: Behavioral and Molecular Changes upon Interaction
Stem Cells, September 1, 2005; 23(8): 1180 - 1191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ioannidis, L. G. Mahaira, S. A. Perez, A. D. Gritzapis, P. A. Sotiropoulou, G. J. Kavalakis, A. I. Antsaklis, C. N. Baxevanis, and M. Papamichail
CRD-BP/IMP1 Expression Characterizes Cord Blood CD34+ Stem Cells and Affects c-myc and IGF-II Expression in MCF-7 Cancer Cells
J. Biol. Chem., May 20, 2005; 280(20): 20086 - 20093.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L. C. Jones, A. Tefferi, P. T. Vuong, J. C. Desmond, W.-K. Hofmann, and H. P. Koeffler
Detection of Aberrant Gene Expression in CD34+ Hematopoietic Stem Cells from Patients with Agnogenic Myeloid Metaplasia Using Oligonucleotide Microarrays
Stem Cells, May 1, 2005; 23(5): 631 - 637.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Manfredini, R. Zini, S. Salati, M. Siena, E. Tenedini, E. Tagliafico, M. Montanari, T. Zanocco-Marani, C. Gemelli, T. Vignudelli, et al.
The Kinetic Status of Hematopoietic Stem Cell Subpopulations Underlies a Differential Expression of Genes Involved in Self-Renewal, Commitment, and Engraftment
Stem Cells, April 1, 2005; 23(4): 496 - 506.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
W. Tse and M. J. Laughlin
Umbilical Cord Blood Transplantation: A New Alternative Option
Hematology, January 1, 2005; 2005(1): 377 - 383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Leukocyte Biology.